Qiagen Investor Relations Material
Latest events
Q2 2025
Qiagen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Qiagen N.V.
Access all reports
Qiagen N.V. is a global biotechnology company specializing in sample and assay technologies for molecular diagnostics, life sciences research, and pharmaceutical development. The company provides solutions for DNA, RNA, and protein analysis, serving applications in disease detection, genetic research, and forensic testing. Qiagen’s products include reagents, instruments, and bioinformatics software used by healthcare providers, academic institutions, and biopharmaceutical companies. Qiagen N.V. is headquartered in Venlo, Netherlands, and its shares are listed on the NYSE and the Frankfurt Stock Exchange.
Key slides for Qiagen N.V.
Q2 2025
Qiagen N.V.
43rd Annual J.P. Morgan Healthcare Conference 2025
Qiagen N.V.
Latest articles
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
Ticker symbol
QGEN
Country
🇺🇸 United States